08/06/2026
A total of 15,000 doses of injectable Lenacapavir (LEN) for use as a pre-exposure prophylaxis (PrEP) against HIV are expected to arrive in the country through a Philippine-United States partnership, the Department of Health (DOH) said on Monday.
PrEP is among the most effective methods to stay protected against Human Immunodeficiency Virus (HIV), which attacks the immune system, particularly cells that help the body fight infections.
Unlike oral PrEP, which is regularly taken one pill every day, LEN is administered once every six months for people who test negative for HIV.
Read more:
https://www.gmanetwork.com/news/topstories/nation/990652/15-000-doses-of-injectable-prep-for-hiv-protection-to-ar